Bruker Statistics
Total Valuation
Bruker has a market cap or net worth of $10.17 billion. The enterprise value is $11.84 billion.
| Market Cap | 10.17B |
| Enterprise Value | 11.84B |
Important Dates
The next estimated earnings date is Monday, November 2, 2026, before market open.
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | Sep 21, 2026 |
Share Statistics
Bruker has 152.36 million shares outstanding. The number of shares has increased by 0.13% in one year.
| Current Share Class | 152.36M |
| Shares Outstanding | 152.36M |
| Shares Change (YoY) | +0.13% |
| Shares Change (QoQ) | -0.26% |
| Owned by Insiders (%) | 31.89% |
| Owned by Institutions (%) | 95.57% |
| Float | 103.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 29.60 |
| PS Ratio | 2.85 |
| Forward PS | 2.76 |
| PB Ratio | 4.13 |
| P/TBV Ratio | 119.21 |
| P/FCF Ratio | 106.39 |
| P/OCF Ratio | 52.47 |
| PEG Ratio | 6.33 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.55, with an EV/FCF ratio of 124.18.
| EV / Earnings | n/a |
| EV / Sales | 3.33 |
| EV / EBITDA | 21.55 |
| EV / EBIT | 37.49 |
| EV / FCF | 124.18 |
Financial Position
The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.76.
| Current Ratio | 1.85 |
| Quick Ratio | 0.80 |
| Debt / Equity | 0.76 |
| Debt / EBITDA | 3.10 |
| Debt / FCF | 19.76 |
| Interest Coverage | 5.06 |
Financial Efficiency
Return on equity (ROE) is -3.00% and return on invested capital (ROIC) is 7.60%.
| Return on Equity (ROE) | -3.00% |
| Return on Assets (ROA) | 3.14% |
| Return on Invested Capital (ROIC) | 7.60% |
| Return on Capital Employed (ROCE) | 6.41% |
| Weighted Average Cost of Capital (WACC) | 9.69% |
| Revenue Per Employee | $315,706 |
| Profits Per Employee | -$9,644 |
| Employee Count | 11,085 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 1.54 |
Taxes
In the past 12 months, Bruker has paid $40.40 million in taxes.
| Income Tax | 40.40M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +114.85% in the last 52 weeks. The beta is 1.23, so Bruker's price volatility has been higher than the market average.
| Beta (5Y) | 1.23 |
| 52-Week Price Change | +114.85% |
| 50-Day Moving Average | 58.86 |
| 200-Day Moving Average | 49.14 |
| Relative Strength Index (RSI) | 64.45 |
| Average Volume (20 Days) | 2,188,094 |
Short Selling Information
The latest short interest is 12.49 million, so 8.20% of the outstanding shares have been sold short.
| Short Interest | 12.49M |
| Short Previous Month | 12.01M |
| Short % of Shares Out | 8.20% |
| Short % of Float | 12.05% |
| Short Ratio (days to cover) | 6.29 |
Income Statement
In the last 12 months, Bruker had revenue of $3.50 billion and -$106.90 million in losses. Loss per share was -$0.70.
| Revenue | 3.50B |
| Gross Profit | 1.70B |
| Operating Income | 311.00M |
| Pretax Income | -24.10M |
| Net Income | -106.90M |
| EBITDA | 541.10M |
| EBIT | 311.00M |
| Loss Per Share | -$0.70 |
Balance Sheet
The company has $184.90 million in cash and $1.86 billion in debt, with a net cash position of -$1.67 billion or -$10.96 per share.
| Cash & Cash Equivalents | 184.90M |
| Total Debt | 1.86B |
| Net Cash | -1.67B |
| Net Cash Per Share | -$10.96 |
| Equity (Book Value) | 2.44B |
| Book Value Per Share | 15.63 |
| Working Capital | 1.02B |
Cash Flow
In the last 12 months, operating cash flow was $190.40 million and capital expenditures -$96.50 million, giving a free cash flow of $93.90 million.
| Operating Cash Flow | 190.40M |
| Capital Expenditures | -96.50M |
| Depreciation & Amortization | 230.10M |
| Net Borrowing | -574.60M |
| Free Cash Flow | 93.90M |
| FCF Per Share | $0.62 |
Margins
Gross margin is 48.48%, with operating and profit margins of 8.89% and -2.03%.
| Gross Margin | 48.48% |
| Operating Margin | 8.89% |
| Pretax Margin | -0.69% |
| Profit Margin | -2.03% |
| EBITDA Margin | 15.46% |
| EBIT Margin | 8.89% |
| FCF Margin | 2.68% |
Dividends & Yields
This stock pays an annual dividend of $0.20, which amounts to a dividend yield of 0.30%.
| Dividend Per Share | $0.20 |
| Dividend Yield | 0.30% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | 32.45% |
| Buyback Yield | -0.13% |
| Shareholder Yield | 0.17% |
| Earnings Yield | -1.07% |
| FCF Yield | 0.94% |
Analyst Forecast
The average price target for Bruker is $62.08, which is -7.00% lower than the current price. The consensus rating is "Buy".
| Price Target | $62.08 |
| Price Target Difference | -7.00% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 4.43% |
| EPS Growth Forecast (3Y) | 14.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bruker has an Altman Z-Score of 2.53 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.53 |
| Piotroski F-Score | 6 |